A Study of PD-1/CTLA-4 Bispecific AK104 in Relapsed or Refractory Peripheral T-cell Lymphoma

Clinical trial NCT04444141 · TERMINATED

Trial details

NCT number: NCT04444141
Sponsor: Akeso
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma

Start date: 2020-05-15
Primary completion: 2022-09-30
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.